Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FHLC vs HIAHX overlap: 71% of top holdings shared

Bottom line

How much do FHLC and HIAHX overlap?

71% of their top holdings overlap by weight. 19 securities appear in both funds' top 25, making up 60.9% of FHLC's assets and 62.2% of HIAHX's. They are largely the same portfolio — owning both adds little diversification.

FHLC holds far more positions (337 vs 79), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FHLCHIAHX
Weight overlap (top 25)71%
Shared holdings19
Weight in shared holdings60.9%62.2%
Total positions33779
Expense ratio0.084%0.94%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings FHLC and HIAHX have in common

Holding% of FHLC% of HIAHXOverlap
Eli Lilly & Co13.35%12.47%12.47%
Johnson & Johnson8.93%6.63%6.63%
AbbVie Inc6.42%3.43%3.43%
UnitedHealth Group Inc5.44%4.72%4.72%
Merck & Co Inc4.66%6.60%4.66%
Thermo Fisher Scientific Inc3.09%1.64%1.64%
Abbott Laboratories2.66%2.10%2.10%
CVS Health Corp1.92%2.93%1.92%
Intuitive Surgical Inc1.82%2.99%1.82%
Danaher Corp1.80%2.65%1.80%
Vertex Pharmaceuticals Inc1.76%2.69%1.76%
Stryker Corp1.62%1.17%1.17%
Medtronic PLC1.59%1.02%1.02%
Elevance Health Inc1.19%2.96%1.19%
Regeneron Pharmaceuticals Inc1.15%1.52%1.15%
Boston Scientific Corp1.00%1.19%1.00%
HCA Healthcare Inc0.91%1.60%0.91%
Cencora Inc0.83%2.07%0.83%
Cardinal Health Inc0.78%1.81%0.78%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FHLC

  1. Amgen Inc — 3.00%
  2. Gilead Sciences Inc — 2.34%
  3. Pfizer Inc — 2.06%
  4. Bristol-Myers Squibb Co — 1.93%
  5. McKesson Corp — 1.52%
  6. Cigna Group/The — 1.06%

Only in HIAHX

  1. Edwards Lifesciences Corp — 2.42%
  2. Biogen Inc — 1.41%
  3. Agilent Technologies Inc — 1.36%
  4. Gsk Plc — 1.21%
  5. Centene Corp — 1.16%
  6. United Therapeutics Corp — 0.96%

Asset mix

Asset typeFHLCHIAHX
Stocks99.7%96.8%
Repurchase agreements—0.7%
Cash & short-term funds0.2%0.4%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryFHLCHIAHX
US96.5%87.9%
IE2.2%2.3%
GB0.5%2.3%
NL0.1%1.8%
BE—0.8%
DK—0.8%
CN—0.6%
CH0.1%0.6%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do FHLC and HIAHX overlap?
About 71% by weight. 19 securities appear in both funds' top 25 holdings; they make up 60.9% of FHLC's assets and 62.2% of HIAHX's. They are largely the same portfolio — owning both adds little diversification.
What stocks do FHLC and HIAHX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, UnitedHealth Group Inc, Merck & Co Inc, AbbVie Inc.
Should I own both FHLC and HIAHX?
Owning both adds little diversification: most of their top holdings are the same, so most investors pick one — often the one with the lower expense ratio.
Which holds more stocks, FHLC or HIAHX?
FHLC is broader, with 337 positions versus 79 for HIAHX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.